
CV · NASDAQ
CapsoVision, Inc.
$6.99 +0.17 (+2.50%)
Company overview
CapsoVision is a medical-technology company that develops advanced capsule endoscopy systems, including the CapsoCam Plus and CapsoCam Colon, as well as AI-enabled imaging platforms for gastrointestinal diagnostics.
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Exchange
- NASDAQ
- Market cap
- $372M
- Employees
- 99
- Headquarters
- Saratoga, CA
- Website
- capsovision.com
- CEO
- Kang-Huai Wang
- Listed
- July 2, 2025
- P/E
- -6.66
- Dividend yield
- 0.00%
Company financials
- Revenue
- $13.6M
- Gross profit
- $7M
- Operating income
- $5.6M
- EBITDA
- -$26.6M
- Net income
- -$27M
- EPS
- -$1.05
- Total assets
- $25.9M
- Total debt
- $788,000
- Gross margin
- 51.67%
- Net margin
- -198.87%
- Earnings yield
- -15.02%
No product segmentation.
Showing FY 2025
News
| Ticker | Type | Headline | Source | Published |
|---|---|---|---|---|
Loading headlines… | ||||